Allena Pharmaceuticals is dedicated to developing and commercializing first-in-class, oral enzyme therapeutics to treat patients with rare and severe metabolic disorders that affect the kidney. The company is focused on metabolic disorders that result in excess accumulation of certain metabolites, such as oxalate and urate, that can cause kidney stones, damage the kidney, and potentially lead to chronic kidney disease, or CKD, and end-stage renal disease.

Biotechnology

Allena Pharmaceuticals

Louis Brenner

Richard Katz

Geoffrey Swire

Stephen Yu

David J. Clark

Hugh Wight

The Finance and Operations team at Allena Pharmaceuticals is responsible for managing the company's financial health and ensuring efficient operational processes. This includes financial planning and analysis, regulatory compliance, quality oversight, and corporate development to support the commercialization of innovative enzyme therapeutics for rare kidney-related metabolic disorders.

Finance and Operations

Leadership Team

Medical & Clinical Operations

Finance and Operations

About

Team members

Other teams at Allena Pharmaceuticals

Leadership Team

Medical & Clinical Operations